Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation.

Nonalcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome that is closely associated with obesity, dyslipidemia, insulin resistance, and type 2 diabetes, thus suggesting that NAFLD represents another component of the metabolic syndrome (1,2). Because it is now recognized that individuals with the metabolic syndrome are at increased cardiovascular risk (3–5), it is possible to hypothesize that NAFLD patients might portend a greater cardiovascular disease (CVD) risk. Ultrasonographically measured carotid intima-media thickness (CIMT), as a reliable index of subclinical atherosclerosis (6), can be used to characterize the CVD risk of patients with NAFLD. However, the available data on this specific topic are lacking. We compared CIMT values in subjects with and without nonalcoholic hepatic steatosis (HS) and examined whether such differences were mediated by one or more metabolic disorders typically clustering in these subjects. We studied 85 male volunteers who were randomly selected among those who agreed to have an evaluation of their liver and intra-abdominal fat by ultrasonography and computed tomography (CT) scan, respectively. The exclusion criteria were as follows: age >50 years combined with an alcohol consumption ≥20 g/day, taking any drugs, and a history of recent acute illness or clinical evidence suggestive of any cardiovascular events, diabetes, or kidney or liver disorders. All individuals were clinically healthy. Most subjects were abstainers ( n = 68) or drank minimally …

[1]  Latha Palaniappan,et al.  Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. , 2004, Diabetes care.

[2]  E. Bonora,et al.  The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[3]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[4]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[5]  M. Bond,et al.  Association of Obesity and Central Fat Distribution With Carotid Artery Wall Thickening in Middle-Aged Women , 2002, Stroke.

[6]  J. Polak,et al.  Intima-media thickness: a tool for atherosclerosis imaging and event prediction. , 2002, The American journal of cardiology.

[7]  M. Stegnar,et al.  Impact of weight reduction on early carotid atherosclerosis in obese premenopausal women. , 2001, Obesity research.

[8]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[9]  T. Lakka,et al.  Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. , 2001, Atherosclerosis.

[10]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[11]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[12]  K. Karason,et al.  Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects , 1999, International Journal of Obesity.

[13]  E. Bonora,et al.  Intimal-Medial Thickness of the Carotid Artery in Nondiabetic and NIDDM Patients: Relationship with insulin resistance , 1997, Diabetes Care.

[14]  M. Muggeo,et al.  Liver Steatosis and Its Relation to Plasma Haemostatic Factors in Apparently Healthy Men - Role of the Metabolic Syndrome , 1996, Thrombosis and Haemostasis.

[15]  G. Targher,et al.  Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Folsom,et al.  Relation of Carotid Artery Wall Thickness to Diabetes Mellitus, Fasting Glucose and Insulin, Body Size, and Physical Activity , 1994, Stroke.

[17]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.